Cambridge Heart, Inc. Earnings Conference Call (Q4 2007)  Today's Calls

Visit the TF Network Sites· Corporate IR Center · Institutional Investor Center · Individual Investor Center Download Plug-In Real Player 8 Basic Windows Media Player Other Conference Calls Other Feb 22 Calls Today's Calls

Call Details Cambridge Heart, Inc. Earnings Conference Call (Q4 2007) Fri, Feb 22, 2008, 4:30 pm Eastern Listen to the archived event audio About Cambridge Heart, Inc. (OTC BB:CAMH.OB) Cambridge Heart, Inc. engages in the research, development, and commercialization of products for the non-invasive diagnosis of cardiac disease in the United States and internationally. Its products primarily include the Heartwave II System used to perform a Microvolt T-Wave Alternans Test, which requires an elevated heart rate to provide an accurate result; the Micro-V Alternans Sensors, which are single patient use, multi-segment electrodes that are required for the Microvolt T-Wave Alternans Test; the CH 2000 Cardiac Stress Test System, a diagnostic system designed to support a range of standard and physician-customized protocols for the conduct and measurement of cardiac exercise stress tests. Cambridge Heart sells its products primarily to cardiology group practices, hospitals, and research institutions through sales representatives and independent distributors. The company was founded in 1990 and is based in Bedford, Massachusetts. More Info: Quote | Chart | News | Profile | Reports | Research | SEC | Insider | Financials | Analyst Ratings